Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19
Status:
Recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
Currently COVID-19 is an international public health emergency. Most COVID-19 patients have
mild or uncomplicated disease, but approximately 14% develop severe disease that requires
hospitalization and oxygen therapy, and up to 5% of patients require admission to Intensive
Care Units.
To date, the only treatments that have shown efficacy in a clinical trial are remdesivir and
dexamethasone. The main objective is to provide reliable estimates on the effects of
different treatment strategies on the outcome and mortality of patients with SARS-CoV-2
infection.
Phase:
Phase 3
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz